z-logo
open-access-imgOpen Access
Rheumatic Diseases
Author(s) -
Johan Frostegård
Publication year - 2010
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.110.204545
Subject(s) - medicine , dermatology
The inflammatory nature of atherosclerosis was previously described by the Austrian pathologist Carl von Rokitansky in the 1840s and by Rudolf Virchow somewhat later.1 Although Rokitansky believed that the inflammation was secondary to other disease processes, Virchow promoted atherosclerosis as a primary inflammatory disease. It appears that Virchow had a point. Even in Rokitansky′s own arterial specimens, activated T cells and other inflammatory cells are present at an early stage of disease, which argues for the opinions of Virchow.1 On the other hand, as is demonstrated in the meta-analysis in the present issue of Arteriosclerosis, Thrombosis, and Vascular Biology, rheumatic diseases are associated with increased atherosclerosis.2 Thus, it is plausible that both Rokitansky and Virchow were right, that both possibilities were nonmutually exclusive.See accompanying article on page 1014 It is somewhat surprising that little attention was paid to the inflammatory nature of atherosclerosis in general until the 1980s.3,4 Thus, atherosclerosis is an inflammatory process in large and middle-sized arteries, characterized by infiltration of the intima by activated monocytes/macrophages and T cells.5,6 Proinflammatory cytokines are produced by immune-competent …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom